Email this article Management and results of treatment of patients with refractory ovarian cancerr
- Authors: Kormosh N.G.1, Laktionov K.P.1
-
Affiliations:
- Research Institute of Clinical Oncology of N.N. Blokchin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow
- Issue: No 3 (2011)
- Pages: 88-95
- Section: GYNECOLOGY. TREATMENT
- Published: 14.08.2011
- URL: https://ojrs.abvpress.ru/ojrs/article/view/184
- DOI: https://doi.org/10.17650/1994-4098-2011-0-3-88-95
- ID: 184
Cite item
Full Text
Abstract
The results of observation of 22 patients with refractory ovarian cancer were analyzed. The usefulness of chemotherapy the second and subsequent lines of treatment is shown. Sequential treatment by not cross-resistant chemotherapy allows increase median survival up to 12.5 months in general group. In 36 % of patients with good performance status prolonged stabilization of disease with median overall survival of 22.3 months was achieved.
About the authors
N. G. Kormosh
Research Institute of Clinical Oncology of N.N. Blokchin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: nkormosh@hotmail.com
Russian Federation
K. P. Laktionov
Research Institute of Clinical Oncology of N.N. Blokchin Russian Cancer Research Center of Russian Academy of Medical Sciences, MoscowRussian Federation
References
Supplementary files
